论文部分内容阅读
2002年1月至2007年8月,我们对112例贲门癌患者实施术中瘤体活性蓝标记。根据着色情况,观察瘤体所在部位的淋巴回流途径,决定术中淋巴结清扫范围,以达到既清除转移淋巴结,又不过多切除尚未转移的淋巴结,提高根治效果,现将初步临床研究结果报告如下。资料与方法一、临床资料本组
From January 2002 to August 2007, we performed intraoperative tumor reactive blue labeling of 112 patients with cardiac cancer. According to the coloring situation, observe the lymphatic flow pathways of the tumor site, determine the range of lymph node dissection in order to achieve both the removal of metastatic lymph nodes, but not excessive resection of lymph nodes have not yet been transferred to improve the curative effect, the preliminary clinical study results are reported as follows. Materials and Methods First, the clinical data of this group